Drugs / DELIGOPARIN SODIUM
DELIGOPARIN SODIUM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00033943 | Jan 2001 → Sep 2002 | ulcerative colitis | Incara Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DELIGOPARIN SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109081 ↗ |
| Known as | deligoparin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00033943 ↗ |
| Known as | Deligoparina sodica | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109081 ↗ |
| Known as | Deligoparine sodique | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109081 ↗ |
| Known as | OP2000 | “experimental compound OP2000 (deligoparin)” NCT00033943 ↗ |
| Route | Subcutaneous | “Study drug will be administered by subcutaneous (under the skin) injection” NCT00033943 ↗ |